NJ hospital treated 1 of 7 women who developed blood clots after J&J vaccine
TRENTON, N.J. (1010 WINS) -- One of seven women who developed blood clots after receiving a Johnson & Johnson COVID-19 vaccine was hospitalized in New Jersey for treatment, according to a report.
A 26-year-old Pennsylvania woman with obesity "got the shot, and seven days later, presented with symptom onset," ABC News reported.
The woman received treatment at a New Jersey hospital, ABC7 confirmed with the state's health department. She has since been released, according to ABC News.
Six other women developed blood clots after receiving the J&J vaccine, one of whom passed away and one of whom was hospitalized in critical condition, the New York Times reported.
A man also developed a clot after receiving the vaccine during a clinical trial, the outlet reported.
More than 7 million others in the U.S., however, have gotten J&J COVID-19 vaccines without experiencing any "serious adverse reactions," the outlet noted.
Investigators have not yet linked the blood clots to the vaccine, but the U.S. Food & Drug Administration and the Centers for Disease Control on Tuesday advised states to put a "pause" on J&J vaccine use "out of an abundance of caution."
"Right now, these adverse events appear to be extremely rare," the agencies said in a joint press release. "COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously."
